MedAssets MHIS Company Profile

01:41 EDT 26th May 2015 | BioPortfolio

MedAssets (NASDAQ: MDAS) partners with healthcare providers to improve financial strength by implementing spend management and revenue cycle management solutions that help control cost, improve margins and cash flow, increase regulatory compliance and optimize operational efficiency. MedAssets serves more than 180 health systems, 4,000 hospitals and 75,000 non-acute healthcare providers. For more information, visit www.medassets.com.


News Articles [27 Associated News Articles listed on BioPortfolio]

Misonix announces supply agreement with MedAssets for BoneScalpel and SonicOne surgical technologies

Misonix has entered into an exclusive three-year national supply contract with MedAssets, one of the nation's largest third-party providers of supply chain management and procurement capabilities.

MedAssets Names LSA Diverse Supplier of the Year

Company Recognized for its Commitment to Diversity and Inclusion for Improved Patient Care Language Services Associates (LSA), a leading provider of interpretation, ...

MedAssets Reports First Quarter 2015 Financial Results

ATLANTA, April 29, 2015 (GLOBE NEWSWIRE) -- MedAssets, Inc. (Nasdaq:MDAS) today announced results for its first quarter ended March 31, 2015, which are summarized below. ($ in millions,...

MedAssets to Participate in the Oppenheimer Healthcare Conference on December 11, 2014

ATLANTA, Dec. 4, 2014 (GLOBE NEWSWIRE) -- MedAssets (Nasdaq:MDAS) today announced that it will participate in the 25th annual Oppenheimer Healthcare Conference in New York City on Thursday, December ...

MedAssets to Present at the J.P. Morgan Healthcare Conference on January 13th

ATLANTA, Jan. 2, 2015 (GLOBE NEWSWIRE) -- MedAssets (Nasdaq:MDAS) today announced that it will present at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2015 in San Francis...

MedAssets Announces Extension of Share Repurchase Plan and Increase to $100 Million

ATLANTA, Feb. 17, 2015 (GLOBE NEWSWIRE) -- MedAssets, Inc. (Nasdaq:MDAS) today announced that its board of directors authorized an extension of the existing share repurchase program to February 29, 2...

John A. Bardis to Retire; R. Halsey Wise Named Chairman and CEO of MedAssets

ATLANTA, Feb. 17, 2015 (GLOBE NEWSWIRE) -- MedAssets, Inc. (Nasdaq:MDAS) today announced that R. Halsey Wise has been appointed chairman and chief executive officer of the company, effective immediat...

MedAssets to Present at the Barclays Global Healthcare Conference on March 11th

ATLANTA, Feb. 26, 2015 (GLOBE NEWSWIRE) -- MedAssets (Nasdaq:MDAS) today announced that it will present at the Barclays Global Healthcare Conference on Wednesday, March 11, 2015 in Miami. The company...

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.

Objective: Polycystic kidney disease (PKD) is a clinically and genetically heterogeneous class of genetic disorders characterized by development of renal cysts leading to renal failure and end stage r...

Clinical Trials [0 Results]

None

Companies [8 Associated Companies listed on BioPortfolio]

MedAssets MHIS

MedAssets (NASDAQ: MDAS) partners with healthcare providers to improve financial strength by implementing spend management and revenue cycle management solutions that help control...

MedAssets, Inc.

MedAssets (NASDAQ: MDAS) partners with healthcare providers to improve their financial strength by implementing spend management and revenue cycle solutions that help control cost...

MedAssets Inc.

MedAssets (NASDAQ: MDAS) partners with healthcare providers to improve their financial strength by implementing spend and clinical resource management and revenue cycle management...

MedAssets Analytical Systems

Our mission is to be the recognized market share leader in the healthcare business chain services segment in which we compete, as measured by the satisfaction and loyalty of our employees, customers, ...

Healthcare Performance Partners

Healthcare Performance Partners, a MedAssets Company, based in Gallatin, Tenn., helps the healthcare workforce see its work with new eyes. Its organizational and process improveme...

More Information about "MedAssets MHIS" on BioPortfolio

We have published hundreds of MedAssets MHIS news stories on BioPortfolio along with dozens of MedAssets MHIS Clinical Trials and PubMed Articles about MedAssets MHIS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MedAssets MHIS Companies in our database. You can also find out about relevant MedAssets MHIS Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

The Top 100 Pharmaceutical Companies
Latest News Clinical Trials Research Drugs Reports Corporate
Top 100 Pharmaceutical Companies 2012 (SCRIP 100 - http://www.scrip100.com/scrip100.html) Rank (2011 in Brackets) Company SEARCH FOR COMPANY IN BIOPORTFOLIO'S BIOCORPORATE DATABASE 2012 pharma sales...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record